biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by roadking08on Oct 13, 2017 9:08pm

138 Views

Post# 26812725

RE:RE:RE:RE:Readership - buck up - listen up...

Kayaycker, this is of a NR of rvx that will be of a tell tell story. Has nothing comparable with bioasis in my opinion but since when that does count.
That NR of rvx could much be read in the future of that 5 letter word of GREED.
that said boys and girls, my money is on rvx while waiting for Santa on this chimney drop from BTI, Sell our great and famous Bioasis and buy RVX! In the meantime my calculator will count your profits and losses.
You have the weekend to decide how much you like money.

Bullboard Posts

How one company is disrupting PoC testing